Found: 166
Select item for more details and to access through your institution.
α‐Synuclein Seed Amplification Assays from Blood‐Based Extracellular Vesicles in Parkinson's Disease: An Evaluation of the Evidence.
- Published in:
- Movement Disorders, 2024, v. 39, n. 8, p. 1269, doi. 10.1002/mds.29923
- By:
- Publication type:
- Article
Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials.
- Published in:
- Movement Disorders, 2024, v. 39, n. 8, p. 1329, doi. 10.1002/mds.29866
- By:
- Publication type:
- Article
Author Correction: Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson's disease.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice.
- Published in:
- Movement Disorders, 2024, v. 39, n. 6, p. 929, doi. 10.1002/mds.29802
- By:
- Publication type:
- Article
Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00714-1
- By:
- Publication type:
- Article
Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.
- Published in:
- Acta Neuropathologica Communications, 2024, v. 12, p. 1, doi. 10.1186/s40478-024-01761-8
- By:
- Publication type:
- Article
A topographical atlas of α-synuclein dosage and cell type-specific expression in adult mouse brain and peripheral organs.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00672-8
- By:
- Publication type:
- Article
Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach.
- Published in:
- Movement Disorders, 2024, v. 39, n. 3, p. 462, doi. 10.1002/mds.29708
- By:
- Publication type:
- Article
A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease.
- Published in:
- Movement Disorders, 2024, v. 39, n. 2, p. 259, doi. 10.1002/mds.29683
- By:
- Publication type:
- Article
Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 1, p. 91, doi. 10.1002/alz.13386
- By:
- Publication type:
- Article
Plasma biomarkers of Alzheimer's disease in dementia with Lewy bodies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078099
- By:
- Publication type:
- Article
The Increasing Prevalence of REM Sleep Behavior Disorder with Parkinson's Disease Progression: A Polysomnography‐Supported Study.
- Published in:
- Movement Disorders Clinical Practice, 2023, v. 10, n. 12, p. 1769, doi. 10.1002/mdc3.13908
- By:
- Publication type:
- Article
C1q is increased in cerebrospinal fluid‐derived extracellular vesicles in Alzheimer's disease: A multi‐cohort proteomics and immuno‐assay validation study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 11, p. 4828, doi. 10.1002/alz.13066
- By:
- Publication type:
- Article
Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta‐Analysis.
- Published in:
- Movement Disorders, 2023, v. 38, n. 9, p. 1585, doi. 10.1002/mds.29497
- By:
- Publication type:
- Article
Status of Current Biofluid Biomarkers in Parkinson's Disease.
- Published in:
- Movement Disorders Clinical Practice, 2023, v. 10, n. 1, p. S18, doi. 10.1002/mdc3.13753
- By:
- Publication type:
- Article
Status of Current Biofluid Biomarkers in Parkinson's Disease.
- Published in:
- Movement Disorders Clinical Practice, 2023, v. 10, p. S18, doi. 10.1002/mdc3.13753
- By:
- Publication type:
- Article
Defining the Riddle in Order to Solve It: There Is More Than One "Parkinson's Disease".
- Published in:
- Movement Disorders, 2023, v. 38, n. 7, p. 1127, doi. 10.1002/mds.29419
- By:
- Publication type:
- Article
Impact of the Dopamine System on Long‐Term Cognitive Impairment in Parkinson Disease: An Exploratory Study.
- Published in:
- Movement Disorders Clinical Practice, 2023, v. 10, n. 6, p. 943, doi. 10.1002/mdc3.13751
- By:
- Publication type:
- Article
Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 5, p. 696, doi. 10.1002/acn3.51753
- By:
- Publication type:
- Article
Instrumental Drift in Untargeted Metabolomics: Optimizing Data Quality with Intrastudy QC Samples.
- Published in:
- Metabolites (2218-1989), 2023, v. 13, n. 5, p. 665, doi. 10.3390/metabo13050665
- By:
- Publication type:
- Article
LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00468-2
- By:
- Publication type:
- Article
Accurate Detection of α‐Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort.
- Published in:
- Movement Disorders, 2023, v. 38, n. 4, p. 567, doi. 10.1002/mds.29329
- By:
- Publication type:
- Article
LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00468-2
- By:
- Publication type:
- Article
A proteogenomic view of Parkinson's disease causality and heterogeneity.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00461-9
- By:
- Publication type:
- Article
CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 1, p. 209, doi. 10.1093/brain/awac261
- By:
- Publication type:
- Article
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease.
- Published in:
- Movement Disorders, 2023, v. 38, n. 1, p. 68, doi. 10.1002/mds.29257
- By:
- Publication type:
- Article
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort.
- Published in:
- NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00404-w
- By:
- Publication type:
- Article
Studying the Parkinson's disease metabolome and exposome in biological samples through different analytical and cheminformatics approaches: a pilot study.
- Published in:
- Analytical & Bioanalytical Chemistry, 2022, v. 414, n. 25, p. 7399, doi. 10.1007/s00216-022-04207-z
- By:
- Publication type:
- Article
Rapid eye movement sleep behaviour disorder: Past, present, and future.
- Published in:
- Journal of Sleep Research, 2022, v. 31, n. 4, p. 1, doi. 10.1111/jsr.13612
- By:
- Publication type:
- Article
Evaluation of the PREDIGT score's performance in identifying newly diagnosed Parkinson's patients without motor examination.
- Published in:
- NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00360-5
- By:
- Publication type:
- Article
Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson's disease.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-15874-4
- By:
- Publication type:
- Article
Baseline Cerebrospinal Fluid α-Synuclein in Parkinson's Disease Is Associated with Disease Progression and Cognitive Decline.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 5, p. N.PAG, doi. 10.3390/diagnostics12051259
- By:
- Publication type:
- Article
Transcriptomic analysis reveals an association of FCGBP with Parkinson’s disease.
- Published in:
- NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00415-7
- By:
- Publication type:
- Article
Detection and quantification of Aβ−3–40 (APP669‐711) in cerebrospinal fluid.
- Published in:
- Journal of Neurochemistry, 2022, v. 160, n. 5, p. 578, doi. 10.1111/jnc.15571
- By:
- Publication type:
- Article
Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligence.
- Published in:
- Acta Neuropathologica Communications, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40478-022-01318-7
- By:
- Publication type:
- Article
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Blood DNA methylation provides an accurate biomarker of KMT2B-related dystonia and predicts onset.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 1, p. 32, doi. 10.1001/jamaneurol.2021.4222
- By:
- Publication type:
- Article
Validity and Prognostic Value of a Polygenic Risk Score for Parkinson's Disease.
- Published in:
- Genes, 2021, v. 12, n. 12, p. 1859, doi. 10.3390/genes12121859
- By:
- Publication type:
- Article
Systematic Assessment of 10 Biomarker Candidates Focusing on α‐Synuclein‐Related Disorders.
- Published in:
- Movement Disorders, 2021, v. 36, n. 12, p. 2874, doi. 10.1002/mds.28738
- By:
- Publication type:
- Article
α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease.
- Published in:
- Movement Disorders, 2021, v. 36, n. 11, p. 2508, doi. 10.1002/mds.28639
- By:
- Publication type:
- Article
Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
- Published in:
- PLoS ONE, 2021, v. 16, n. 10, p. 1, doi. 10.1371/journal.pone.0257372
- By:
- Publication type:
- Article
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.705407
- By:
- Publication type:
- Article
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients.
- Published in:
- NPJ Parkinson's Disease, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41531-021-00219-1
- By:
- Publication type:
- Article
Cerebrospinal α‐Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort.
- Published in:
- Movement Disorders, 2021, v. 36, n. 9, p. 2048, doi. 10.1002/mds.28611
- By:
- Publication type:
- Article
Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41531-021-00203-9
- By:
- Publication type:
- Article
Incidence and Progression of Rapid Eye Movement Behavior Disorder in Early Parkinson's Disease.
- Published in:
- Movement Disorders Clinical Practice, 2021, v. 8, n. 4, p. 534, doi. 10.1002/mdc3.13168
- By:
- Publication type:
- Article
Protein Binding Partners of Dysregulated miRNAs in Parkinson's Disease Serum.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 4, p. 791, doi. 10.3390/cells10040791
- By:
- Publication type:
- Article
Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase.
- Published in:
- NPJ Parkinson's Disease, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41531-021-00172-z
- By:
- Publication type:
- Article
Preanalytical Stability of CSF Total and Oligomeric Alpha-Synuclein.
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 13, p. N.PAG, doi. 10.3389/fnagi.2021.638718
- By:
- Publication type:
- Article